FIGURE 3.
(A–E) PET/CT images of 4 patients illustrating 89Zr-atezolizumab tumor uptake in 5 different locations on day 7 after injection (arrows indicate tumors). (F–G) PET/CT images of lesions of 3 patients with heterogeneous intralesional 89Zr-atezolizumab uptake on day 7 after injection: mediastinal lesion of NSCLC patient (SUVmax, 19.9) (F), abdominal wall metastases of bladder cancer patient (SUVmax, 36.4) (G), and bone metastasis of breast cancer patient (SUVmax, 7.1) (H). (Adapted with permission of (81).)